Strategic Wealth Investment Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,307
Closed -$1.08M 130
2024
Q4
$1.08M Sell
3,307
-445
-12% -$140K 0.12% 70
2024
Q3
$1.12M Buy
3,752
+1,082
+41% +$331K 0.12% 70
2024
Q2
$867K Buy
+2,670
New +$944K 0.11% 75

Other funds holding WST

Strategic Wealth Investment Group's WST Position: Q1 2025 in Review

Strategic Wealth Investment Group sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 3,307 shares — an estimated $1.08M sold.

Strategic Wealth Investment Group first reported a position in WST in Q2 2024 and held it in 3 quarters. The position peaked at $1.12M in Q3 2024. 713 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Strategic Wealth Investment Group reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Strategic Wealth Investment Group sold 3,307 West Pharmaceutical shares in Q1 2025, an estimated $1.08M.
  • Strategic Wealth Investment Group first reported a position in West Pharmaceutical in Q2 2024 and held it in 3 quarters.
  • Strategic Wealth Investment Group's West Pharmaceutical position peaked at $1.12M in Q3 2024.
  • 713 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Strategic Wealth Investment Group's 13F filing for Q1 2025, filed 14 Apr 2025.